Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Amphotericin B liposomal 50mg powder for dispersion for infusion vials |
BNF code | 0502030A0AAAIAI |
Virtual Therapeutic Moiety | Amphotericin B liposomal |
Basis of preferred name | Other |
Date of name applicability | 15 Jan 2020 |
Previous name | Amphotericin B liposomal 50mg powder for solution for infusion vials |
Basis of previous name | Other |
Prescribing status | Caution - AMP level prescribing advised |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | vial |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Amphotericin B liposomal |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 50.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | dispersioninfusion.intravenous |
Dose Form | |
Formulation | Powder for dispersion for infusion |
Drug Route | |
Route | Intravenous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Amphotericin B liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) | |
Amphotericin B liposomal 50mg powder for dispersion for infusion vials (Tillomed Laboratories Ltd) | |
Virtual Medicinal Product Packs | |
Amphotericin B liposomal 50mg powder for dispersion for infusion vials 10 vial | |
Amphotericin B liposomal 50mg powder for dispersion for infusion vials 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.